Synact Pharma Aps

This study tests an experimental drug called AP1189 in people with a rare kidney condition called idiopathic membranous nephropathy that causes severe protein leakage in urine. About 23 adults will receive either AP1189 or a placebo for 12 weeks, on top of their usual blood press…

This study tests an experimental oral drug called AP1189, taken alongside methotrexate, for people recently diagnosed with rheumatoid arthritis who have not yet tried disease-modifying drugs. The goal is to see if AP1189 can better control joint inflammation and disease activity …